The European Commission and WHO extend their strategic cooperation to deliver better health for all At the EU-WHO Strategic Dialogue on Health between the European…
New report showcases strategies to keep children safe online A new report published today by the World Health Organization (WHO), What works to prevent online violence…
Lilly Completes Acquisition of Akouos Expanding Efforts to Help People with Genetic Diseases Eli Lilly and Company (NYSE: LLY) announced the successful completion of its acquisition…
Merck to Present Data From Its Hematology Portfolio and Promising Pipeline at the 64th American Society of Hematology (ASH) Annual Meeting RAHWAY, N.J.–(BUSINESS WIRE)– Merck…
WHO calls on the global community to equalize the HIV response On 1 December, World AIDS Day 2022, the World Health Organization (WHO) is calling…
The Netherlands increases its flexible contribution for “a strong and agile WHO” On 29 November 2022, the Ministry of Foreign Affairs of the Netherlands and…
WHO urges more effective prevention of injuries and violence causing 1 in 12 deaths worldwide njuries and violence take the lives of some 12 000…
Republic of Korea achieves the highest WHO level for regulation of medicines and vaccines The World Health Organization (WHO) announces that the Ministry of Food…
FDA Approves First Fecal Microbiota Product Today, the U.S. Food and Drug Administration approved Rebyota, the first fecal microbiota product approved by the agency. Rebyota…
European Commission Grants Expanded Marketing Authorization for Gilead’s Biktarvy® for the Treatment of HIV in Pediatric Populations FOSTER CITY, Calif.–(BUSINESS WIRE)– Gilead Sciences, Inc. (Nasdaq:…
Lilly Shares Positive Donanemab Data in First Active Comparator Study in Early Symptomatic Alzheimer’s Disease Eli Lilly and Company (NYSE: LLY) has announced that donanemab met…
Lilly and Akouos Announce Expiration of Akouos Tender Offer Eli Lilly and Company (NYSE: LLY) and Akouos, Inc. (NASDAQ: AKUS) today announced that the tender offer to purchase all of…